English
  1. Home
  2. Stocks
  3. Indswftlab Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Ind-Swift Laboratories

    Small Cap
    ₹110.25
    -0.05 (-0.05%)
    18 May, 2024 18:29 BSE: 532305 NSE: INDSWFTLABISIN: INE915B01019

    Start SIP in Ind-Swift Laboratories

    Start SIP

    Ind-Swift Laboratories Performance

    Day Range

    • Low 110
    • High 112
    ₹ 110

    52 Week Range

    • Low 65
    • High 138
    ₹ 110
    • Open Price111
    • Previous Close110
    • Volume76536

    Ind-Swift Laboratories Share Price

    • Over 1 Month -8.77%
    • Over 3 Month +3.72%
    • Over 6 Month +17.16%
    • Over 1 Year +67.17%

    Ind-Swift Laboratories Key Statistics

    P/E Ratio 2.1
    PEG Ratio 0
    Market Cap Cr 651
    Price to Book Ratio 0.7
    EPS 24.6
    Dividend 0
    Relative Strength Index 45.69
    Money Flow Index 36.28
    MACD Signal -0.95
    Average True Range 6.83
    Ind-Swift Laboratories Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 382276270299290
    Operating Expenses Qtr Cr 309222207239234
    Operating Profit Qtr Cr 7354636056
    Depreciation Qtr Cr 131413149
    Interest Qtr Cr -1121212022
    Tax Qtr Cr 134561439
    Net Profit Qtr Cr 350223017-31
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,2731,185
    Operating Expenses Annual Cr 977930
    Operating Profit Annual in Cr 250222
    Depreciation Cr 5357
    Interest Annual Cr 5192
    Tax Annual Cr 15937
    Net Profit Annual Cr 41842
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -180183
    Cash from Investing Activity Annual Cr -104-14
    Cash from Financing Annual Activity Cr 700-168
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 922675
    Fixed Assets Annual Cr 8595
    Total Non Current Assets Annual Cr 559714
    Total Current Assets Annual Cr 5461,074
    Total Assets Annual Cr 1,1051,788
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 156113
    ROE Annual % 459
    ROCE Annual % 2614
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2422
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 393288290310304
    Operating Expenses Qtr Cr 431236224250240
    Operating Profit Qtr Cr -3751666065
    Depreciation Qtr Cr 131413149
    Interest Qtr Cr -1121212022
    Tax Qtr Cr 134471441
    Net Profit Qtr Cr 239193217-24
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,3261,241
    Operating Expenses Annual Cr 1,027978
    Operating Profit Annual in Cr 254229
    Depreciation Cr 5357
    Interest Annual Cr 5192
    Tax Annual Cr 16039
    Net Profit Annual Cr 42148
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -181195
    Cash from Investing Activity Annual Cr -104-13
    Cash from Financing Annual Activity Cr 699-186
    Net Cash Flow Annual Cr -4
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 931682
    Fixed Assets Annual Cr 8595
    Total Non Current Assets Annual Cr 504660
    Total Current Assets Annual Cr 6611,165
    Total Assets Annual Cr 1,1651,824
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 158114
    ROE Annual % 4510
    ROCE Annual % 2614
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2322
    Sign Up to Know More
    Invest in Ind-Swift Laboratories

    Ind-Swift Laboratories Technicals

    EMA & SMA

    Current Price
    ₹110.25
    -0.05 (-0.05%)
    pointer
    • Bullish Moving Average
    • ___
    • 6
    • Bearish Moving Average
    • ___
    • 10
    • 20 Day
    • ₹112.92
    • 50 Day
    • ₹112.49
    • 100 Day
    • ₹108.70
    • 200 Day
    • ₹101.02
    • 20 Day
    • ₹115.05
    • 50 Day
    • ₹112.35
    • 100 Day
    • ₹109.66
    • 200 Day
    • ₹101.31

    Ind-Swift Laboratories Resistance and Support

    PIVOT
    ₹110.55
    Resistance
    First Resistance 111.50
    Second Resistance 112.75
    Third Resistance 113.70
    RSI 45.69
    MFI 36.28
    MACD Single Line -0.95
    MACD -1.64
    Support
    First Support 109.30
    Second Support 108.35
    Third Supoort 107.10

    Ind-Swift Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 532,686 29,329,691 55.06
    Week 1,574,974 56,116,309 35.63
    1 Month 832,705 36,738,959 44.12
    6 Month 750,847 38,668,635 51.5

    Ind-Swift Laboratories Result Highlights

    Ind-Swift Laboratories Synopsis

    NSE-Medical-Generic Drugs

    Ind-Swift Laboratori is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1151.96 Cr. and Equity Capital is Rs. 59.81 Cr. for the Year ended 31/03/2023. Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553.
    Market Cap 652
    Sales 1,227
    Shares in Float 3.43
    No of funds 8
    Yield
    Book Value 0.71
    U/D Vol ratio 1.8
    LTDebt / Equity 151
    Alpha 0.13
    Beta 1.22

    Ind-Swift Laboratories Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 42%42%42%42%
    Foreign Portfolio Investors 0.26%0.31%0.17%0.08%
    Individual Investors 30.46%29.27%28.77%29.21%
    Others 27.28%28.42%29.06%28.71%

    Ind-Swift Laboratories Management

    Name Designation
    Mr. Navrattan Munjal Chairman & Managing Director
    Mr. Himanshu Jain Joint Managing Director
    Mr. Rishav Mehta Executive Director
    Mr. Sahil Munjal Executive Director
    Dr. Ashwani Kumar Vig Independent Director
    Mr. Rajinder Kumar Gupta Independent Director
    Mr. S P Sharma Independent Director
    Ms. Neerja Chathley Independent Woman Director

    Ind-Swift Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Ind-Swift Laboratories Corporate Action

    Date Purpose Remarks
    2024-05-13 Audited Results
    2024-02-12 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-09 Quarterly Results
    2023-05-29 Audited Results

    Ind-Swift Laboratories MF Shareholding

    Name Amount(cr)

    Ind-Swift Laboratories FAQs

    What is Share Price of Ind-Swift Laboratories ?

    Ind-Swift Laboratories share price is ₹110 As on 18 May, 2024 | 18:15

    What is the Market Cap of Ind-Swift Laboratories ?

    The Market Cap of Ind-Swift Laboratories is ₹651.4 Cr As on 18 May, 2024 | 18:15

    What is the P/E ratio of Ind-Swift Laboratories ?

    The P/E ratio of Ind-Swift Laboratories is 2.1 As on 18 May, 2024 | 18:15

    What is the PB ratio of Ind-Swift Laboratories ?

    The PB ratio of Ind-Swift Laboratories is 0.7 As on 18 May, 2024 | 18:15

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.